A facile synthesis of a set of deuterium-labeled steroid 3,6-diols with different steroid A/B ring fusion, unsaturations, and configurations of hydroxyl groups at C-3 and C-6 is described. Reduction and deuteration, based on deuterium-exchange of the obtained the cholest-4-ene-3,6-dione from cholesterol using sodium borodeuteride and deuterium water, were used. The obtained steroid diols are intended to be used as precursors in the studies on biosynthesis of some marine polar steroids.
During last years the radio-labeled compounds are displacing by deuterated biosynthetic precursors in the studies on biosyntheses of natural products due to possibilities to recognize a deuterium label in target compounds by mass spectrometry and NMR spectroscopy easily. Actually, these methods allow to determine the number and positions of deuterium atoms in products of biosynthesis. Introduction of deuterium atoms in target compounds may be carried out by chemical reactions of suitable compounds with deuterium-containing reagents. Deuterated steroid derivatives are of interest as biosynthetic precursors of numerous bioactive natural polar steroids, particularly those of marine origin. For example, starfish polar steroids are characterized by a remarkable structural diversity and include various polyhydroxylated steroids, their sulfates and glycosides. Polar steroid metabolites from starfish have been reported to show a wide spectrum of biological activities, including hemolytic, cytotoxic, antiviral, antibacterial, antibiofouling, antifungal, neuritogenic, cancer preventive, and antiinflammatory effects [1] .
At the same time, the biosynthesis of starfish polar steroids remains to be insufficiently studied. Recently, in feeding experiments on the Far Eastern starfish Patiria (=Asterina) pectinifera, we have established that the dietary cholesterol and cholesterol sulfate are biosynthetic precursors of polyhydroxysteroids and related low molecular weight glycosides in starfishes [2] . For these feeding experiments, we have used the commercial [25,26,26,26,27,27,27-2 H 7 ]cholesterol and sulfated by us commercial [2,2,3,4,4,6-2 H 6 ]cholesterol. We have established that at the first stages of biosynthesis sterols and sterol sulfates suffer the transformation in rings A and B including oxidation into corresponding 4(5)unsaturated 3-ketones as biosynthetic intermediates for further oxidations of steroid nucleus [2] . For the next step of the studies on biosynthesis of target compounds we needed deuterium-labeled potential intermediates with different configurations of hydroxyl group at C-6 and different positions of deuterium atoms in the rings A and B, but the suitable compounds are not commercially available. So, we have synthesized the deuterium-labeled steroid 3,6-diols from cholesterol via cholest-4-ene-3,6-dione.
The synthetic route (Scheme 1) started with the oxidation of cholesterol (1) to cholest-4-ene-3,6-dione (2) by the Fieser's method at treatment with Na 2 Cr 2 O 7 •2H 2 O in acetic acid [3] . The Scheme 1: Reagents and conditions: i, Na 2 Cr 2 O 7 •2H 2 O/AcOH, 0ºC, 46 h; ii, 1) NaBH 4 /AcCN, room temperature, 1.5 h, 2) HPLC on Diasfer-110-C18 column in 90% EtOH; iii, 1) NaBD 4 /AcCN, room temperature, 1.5 h, 2) HPLC on Diasfer-110-C18 column in 90% EtOH; iv, 1) D 2 O, Et 3 N/AcCN, 50ºC, 36 h; 2) NaBH 4 /AcCN, room temperature, 1.5 h, 3) HPLC on Diasfer-110-C18 column in 90% EtOH. structure of 2 was established by [M + Na] + sodium adduct ion peak at m/z 421 in the (+)-ESI-MS spectrum and [M -H]  ion peak at m/z 397 in the (-)-ESI-MS spectrum as well as comparison of the 1 H and 13 C NMR data with those of cholest-4-ene-3,6-dione isolated from the sponge Geodia cydonium [4] .
In the model experiment, steroid 2 was reduced by NaBH 4 . As result, we have obtained the mixture of steroid 3,6-diols, which were subjected to chromatographic separation on semi-preparative Diasfer-110-C18 column to yield five major diols 3-7 (Scheme 1). The structures of these compounds were established by NMR spectroscopy and ESI mass spectrometry. The steroids 3 and 4 have 5-steroid nucleus that were confirmed by 13 C NMR signals of C-19 atoms at  C 26.0 and 23.8, respectively, shifted in the downfield region compared to 5-steroids [5] (6), and 5-cholestane-3,6-diol (7) . Although these steroid diols have been reported many years ago [6] [7] [8] [9] , little or no NMR and MS characterization of these compounds were presented in literature. So we assigned all proton and carbon signals of 3-7 using 2D NMR experiments, including 1 H-1 H COSY, HSQC, HMBC, and ROESY (see Supplementary Materials). Moreover, these data will facilitate the further structural elucidation of deuterated products in biosynthetic experiments.
The reduction of steroid 2 by NaBD 4 followed by chromatographic separation of obtained products on semi-preparative Diasfer-110-C18 column yielded the deuterated diols 3a-7a with the same structures of steroid nucleus and configurations of hydroxyl groups which were confirmed by NMR data. The positions of the deuterium atoms at C-3, C-4, C-5, and C-6 were proposed from the synthesis scheme. The incorporations of deuterium atoms in 3a-7a were supported by ESI and EI mass spectra. The extent of deuterium enrichment was higher than 99% which was estimated by analysis of the NMR and mass spectra of deuterated compounds. The localization of deuterium atoms was confirmed by 2 H NMR spectroscopy. All data indicated the presence of two deuterium atoms at C-3 and C-6 in the unsaturated compounds 5a and 6a and four deuterium atoms at C-3, C-4, C-5 and C-6 in the saturated compounds 3a, 4a and 7a (Scheme 1).
For the obtaining of compounds with deuterium atoms in other positions we used the reaction of proton-deuterium exchange in the -positions to the carbonyl functions. It is known that D 2 O in the presence of NaOD in different solvents was used to replace acidic hydrogens to deuterium atoms in -positions to carbonyls of steroids [10, 11] . We added a D 2 O with a small amount of Et 3 N for alkaline condition to a solution of cholest-4-ene-3,6-dione (2) in AcCN. The reaction mixture was refluxed for 36 hours giving cholest-4-ene-3,6-dione with the predominant integration of four deuterium atoms at C-2 and C-7. The incorporating deuterium atoms was monitoring by ESI-MS. No nonlabelled compound has been detected. The isotope enrichment of labeled compound was 93.7%, which was calculated from the mass spectra of the nondeuterated and fully deuterated materials by the method described by González-Antuña et al. [12] . Then we reduced the obtained deuterium-labeled cholest-4-ene-3,6-dione by NaBH 4 and chromatographed the mixture of diols on semi-preparative Diasfer-110-C18 column yielded diols 3b-7b with the same structures of steroid nucleus and configurations of hydroxyl groups which were confirmed by NMR data. The incorporations of deuterium atoms in the 3b-7b also were estimated by ESI and EI mass spectra. The localizations of deuterium atoms were confirmed by 2 H NMR spectroscopy. All the data indicated the presence of the predominant integration of two deuterium atoms at C-2 and two deuterium atoms at C-7 in steroid diols 3b-7b (Scheme 1).
Thus, a set of deuterium-labeled steroid 3,6-diols with trans and cis steroid A/B ring fusions, different level of unsaturation and configurations of hydroxyl groups at C-3 and C-6 was obtained from cholesterol. These compounds will be used for in vivo experiments as potential biosynthetic intermediates in the studies on biosynthesis of starfish polar steroids. Inclusion of deuterium atoms in such positions as 2, 3, 4, 5, 6, and 7 of steroid precursors opens the possibilities to indicate the probable formation of double bonds and/or epoxy function in rings A and B in the process of biosynthesis of starfish polar steroids.
Experimental
General: All reagents were obtained from Sigma-Aldrich and Merck. Optical rotations were determined on a Perkin-Elmer 141 polarimeter. Melting points were determined using a hot stage melting point apparatus model Leica GALEN III equipped with microscope. 1 H and 13 C NMR spectra were recorded on a Bruker Avance III 700 spectrometer at 700.13 and 176.04 MHz, and a Bruker DRX 500 spectrometer at 500.13 and 125.76 MHz, respectively, chemical shifts were referenced to the residual solvent signal  H 7.21/ C 149.65 for C 5 D 5 N. 2 H NMR spectra were recorded on a Bruker Avance III 700 spectrometer at 107.48 MHz, chemical shifts were referenced to the signal of C 5 D 5 N at  H 2.298 in C 5 H 5 N. ESI mass spectra were recorded on an Agilent 6510 Q-TOF LC/MS mass spectrometer; samples were dissolved in MeOH (c 0.01 mg/mL). EI mass spectra were recorded on an AMD604S mass spectrometer. HPLC separations were carried out on an Agilent 1100 Series chromatograph equipped with a differential refractometer, Diasfer-110-C18 (10 m, 250  15 mm) column in 90% EtOH was used. Sorbfil Si gel plates (4.5  6.0 cm, 517 m, Sorbpolimer, Krasnodar, Russia) were used for thin-layer chromatography.
Synthesis of compounds 3-7. General procedure:
A cholest-4-ene-3,6-dione 2 (145 mg) was dissolved in AcCN (2 mL) by heating and reduced by NaBH 4 (50 mg) at room temperature for 1.5 h. The progress of the reaction was monitored by TLC in the eluent system n-hexane/ethylacetate (3:1, v/v). After cooling, the solution was neutralized with AcOH, and the solvent was evaporated trice with MeOH. The mixture CHCl 3 /H 2 O (1:1, v/v) was added to obtained residue and chloroform layer was separated, dried by Na 2 SO 4 and evaporated to give total fraction of 3,6-steroid diols in 99% yield. The fraction was chromatographed by HPLC on the Diasfer-110-C18 column (10 m, 250  15 mm, 2.5 mL/min) with 90% EtOH as eluent to give pure diols 3-7 with t R 27.5, 32.5, 34.9, 42.0, and 50.4 min, respectively. The spectral data of these compounds are provided in Supplementary Materials.
Synthesis of compounds 3a-7a. General procedure:
A cholest-4ene-3,6-dione 2 (665 mg) was dissolved in AcCN (5 mL) by heating and reduced by NaBD 4 (300 mg) at room temperature for 1.5 h. The progress of the reaction was monitored by TLC in the eluent system n-hexane/ethylacetate (3:1, v/v). After cooling, the solution was neutralized with AcOH, and the solvent was evaporated trice with MeOH. The mixture CHCl 3 /H 2 O (1:1, v/v) was added to obtained Synthesis of deuterium-labeled steroid 3,6-diols Natural Product Communications Vol. 12 (9) 2017 1413 residue and chloroform layer was separated, dried by Na 2 SO 4 and evaporated to give total fraction of 3,6-steroid diols in 99% yield. The fraction was chromatographed by HPLC on the Diasfer-110-C18 column (10 m, 250  15 mm, 2.5 mL/min) with 90% EtOH as eluent to give pure diols 3a-7a with t R 27.5, 33.0, 34.9, 42.0, and 50.2 min, respectively. 
